BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17306769)

  • 1. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.
    Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2007 May; 73(10):1558-72. PubMed ID: 17306769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
    Rais RH; Al Safarjalani ON; Yadav V; Guarcello V; Kirk M; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2005 May; 69(10):1409-19. PubMed ID: 15857605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
    Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2008 Oct; 76(8):958-66. PubMed ID: 18755159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological activity and molecular modeling of 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase.
    Yadav V; Chu CK; Rais RH; Al Safarjalani ON; Guarcello V; Naguib FN; el Kouni MH
    J Med Chem; 2004 Apr; 47(8):1987-96. PubMed ID: 15055998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.
    Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; El Kouni MH
    Biochem Pharmacol; 2010 Oct; 80(7):955-63. PubMed ID: 20541538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase.
    Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
    J Med Chem; 2008 Jul; 51(13):3934-45. PubMed ID: 18563892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii.
    Iltzsch MH; Uber SS; Tankersley KO; el Kouni MH
    Biochem Pharmacol; 1995 May; 49(10):1501-12. PubMed ID: 7763293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase.
    Kim YA; Rawal RK; Yoo J; Sharon A; Jha AK; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; El Kouni MH
    Bioorg Med Chem; 2010 May; 18(10):3403-12. PubMed ID: 20456959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Benzylthioinosine analogues: promising anti-toxoplasmic agents as inhibitors of the mammalian nucleoside transporter ENT1 (es).
    Gupte A; Buolamwini JK; Yadav V; Chu CK; Naguib FN; el Kouni MH
    Biochem Pharmacol; 2005 Dec; 71(1-2):69-73. PubMed ID: 16310172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
    el Kouni MH
    Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii.
    el Kouni MH; Guarcello V; Al Safarjalani ON; Naguib FN
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2437-43. PubMed ID: 10508021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant expression, purification, and characterization of Toxoplasma gondii adenosine kinase.
    Darling JA; Sullivan WJ; Carter D; Ullman B; Roos DS
    Mol Biochem Parasitol; 1999 Sep; 103(1):15-23. PubMed ID: 10514077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.
    Cook WJ; DeLucas LJ; Chattopadhyay D
    Protein Sci; 2000 Apr; 9(4):704-12. PubMed ID: 10794412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding.
    Schumacher MA; Scott DM; Mathews II; Ealick SE; Roos DS; Ullman B; Brennan RG
    J Mol Biol; 2000 May; 298(5):875-93. PubMed ID: 10801355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding.
    Schumacher MA; Scott DM; Mathews II; Ealick SE; Roos DS; Ullman B; Brennan RG
    J Mol Biol; 2000 Feb; 296(2):549-67. PubMed ID: 10669608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
    Stec J; Fomovska A; Afanador GA; Muench SP; Zhou Y; Lai BS; El Bissati K; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Sommervile C; Woods S; Roberts CW; Rice D; Prigge ST; McLeod R; Kozikowski AP
    ChemMedChem; 2013 Jul; 8(7):1138-60. PubMed ID: 23776166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies.
    Salin NH; Noordin R; Al-Najjar BO; Kamarulzaman EE; Yunus MH; Karim IZA; Nasim NNM; Zakaria II; Wahab HA
    PLoS One; 2020; 15(5):e0225232. PubMed ID: 32442170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives.
    Carradori S; Secci D; Bizzarri B; Chimenti P; De Monte C; Guglielmi P; Campestre C; Rivanera D; Bordón C; Jones-Brando L
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):746-758. PubMed ID: 28537532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.
    Moine E; Dimier-Poisson I; Enguehard-Gueiffier C; Logé C; Pénichon M; Moiré N; Delehouzé C; Foll-Josselin B; Ruchaud S; Bach S; Gueiffier A; Debierre-Grockiego F; Denevault-Sabourin C
    Eur J Med Chem; 2015 Nov; 105():80-105. PubMed ID: 26479029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Anti-Toxoplasma gondii Activity Evaluation of a New Series of Quinazolin-4(3H)-one Derivatives.
    Deng Y; Mu H; Li HB; Fu LZ; Tang D; Wu T; Huang SH; Li CH
    Chem Biodivers; 2021 Dec; 18(12):e2100687. PubMed ID: 34726832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.